Products

RecovryAI
RecovryAI
Clinical Decision Support & Reference

See all 1 product →

About RecovryAI

RecovryAI is a healthcare AI company specializing in physician-prescribed, patient-facing Virtual Care Assistants (VCAs) designed to optimize post-operative recovery. These AI-powered tools extend continuous clinical supervision from hospital discharge into the patient’s home, a critical period where many complications can arise. The VCAs deliver recovery guidance based on established clinical protocols, continuously evaluate patient-reported information against expected recovery trajectories, and are engineered to escalate any significant deviations to the prescribing physician’s care team with comprehensive clinical context.

The company’s approach aims to manage routine, low-acuity patient concerns, thereby freeing up clinical staff to focus on higher-acuity cases while ensuring that clinicians retain ultimate oversight and medical judgment. RecovryAI emphasizes a structured medical reasoning framework, distinct from open-ended chatbots, and is committed to regulatory compliance. Their initial VCA application targets total joint arthroplasty, with the underlying architecture designed for future expansion into other procedural domains.

Focus Areas

post-operative recovery patient-facing AI virtual care assistants total joint arthroplasty regulated medical devices remote patient monitoring

Business Intelligence

TechnologyCustom-built AI model, mobile-responsive scalable infrastructure, HIPAA adherence and legal compliance, structured medical reasoning framework

What Physicians Need to Know

Specialization
RecovryAI specializes in physician-prescribed, patient-facing Virtual Care Assistants (VCAs) for post-operative recovery, initially focusing on total joint arthroplasty with plans to expand across other procedural domains.
Key Differentiator: Regulatory Status
The company has received FDA Breakthrough Device Designation and is pursuing FDA authorization under a novel Class II pathway for patient-facing Software as a Medical Device (SaMD). This establishes a new class of regulated clinical AI.
Key Differentiator: Clinical Approach
RecovryAI's VCAs are built on a structured medical reasoning framework, not open-ended chat, to provide clear, consistent, and clinically validated recovery guidance based on procedure-specific protocols.
Core Functionality
Virtual Care Assistants engage patients directly, delivering guidance, continuously evaluating patient-reported information against expected recovery trajectories, and escalating meaningful deviations to licensed providers with full clinical context.
Impact on Care Delivery
The platform extends clinical supervision from the facility into the patient's home, bridging the critical gap in post-discharge care where most complications occur and provider visibility is limited.
Technology Stack (Implied)
The system harnesses the ambient intelligence of generative AI within a clinically constrained logic architecture, emphasizing a structured medical reasoning framework for regulated clinical environments.
Physician Tip

For physicians, RecovryAI offers a powerful tool to extend continuous clinical supervision and enhance patient care during the vulnerable post-operative recovery period. The physician-prescribed Virtual Care Assistants manage routine, low-acuity patient concerns, freeing up clinical staff to focus on more complex cases. Physicians gain full visibility into patient progress and receive timely, contextualized alerts for any deviations from expected recovery patterns, potentially leading to earlier intervention and reduced readmissions. The FDA Breakthrough Device Designation and pursuit of Class II SaMD authorization underscore a commitment to safety, accountability, and clinical rigor, providing a strong basis for trust and adoption in practice. This technology strengthens the surgeon-patient connection by providing consistent, protocol-driven guidance while ensuring clinicians retain oversight and final medical judgment.

While specific technical integration details (e.g., direct EHR integration) are not explicitly detailed in the provided information, the system is designed to surface symptoms and escalate concerns to the prescribing physician's care team with full clinical context, implying a functional integration with existing care team workflows and communication channels for seamless oversight and intervention.

Products by RecovryAI

1 product in the directory

RecovryAI
RecovryAI
Clinical Decision Support & Reference

Videos

News, demos, and interviews about RecovryAI.

Loading videos...

Videos load interactively. If none appear, search YouTube for RecovryAI →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

RecovryAI offers Virtual Care Assistants (VCAs), which are physician-prescribed, patient-facing AI chatbots designed to support post-operative recovery at home. These VCAs provide clinically validated guidance, monitor patient progress by asking structured questions twice daily, and automatically escalate deviations or warning signs to the patient's care team with full context. This approach aims to reduce readmissions and improve patient outcomes by extending continuous clinical supervision beyond the hospital setting.
RecovryAI has received FDA Breakthrough Device Designation for its Virtual Care Assistants, marking the first time such status has been granted to a patient-facing generative AI product. The company is actively pursuing FDA authorization under a novel Class II pathway for Software as a Medical Device (SaMD) and is conducting a multi-site pivotal clinical study to demonstrate safety and efficacy. This regulatory engagement is expected to establish a new device classification for patient-facing AI.
RecovryAI's Virtual Care Assistants are physician-prescribed and operate strictly within established clinical protocols, ensuring that the AI provides guidance rather than making independent clinical decisions. The system is designed to escalate any significant deviations or concerns directly to the human care team, maintaining clinician oversight and final medical judgment. While specific data privacy certifications like HIPAA were not detailed in the search results, as a regulated medical device pursuing FDA authorization, adherence to stringent healthcare data security and privacy standards would be a fundamental requirement.
Specific pricing models for RecovryAI's Virtual Care Assistants are not publicly disclosed in the available information. However, healthcare AI solutions often utilize subscription-based models, per-patient fees, or value-based pricing tied to outcomes like reduced readmissions or improved efficiency. Interested healthcare organizations would typically engage directly with RecovryAI for detailed pricing structures.
RecovryAI's system is designed to integrate into existing care pathways by providing continuous patient monitoring and offloading routine patient queries from clinical staff. The AI's primary support function for providers is to intelligently triage patient-reported information and escalate critical issues with comprehensive context, allowing clinicians to focus on higher-acuity cases. While detailed integration specifics were not provided, the physician-prescribed nature implies a workflow designed to complement clinical practice.
RecovryAI is currently conducting its pivotal clinical study at multiple prominent healthcare sites, including OrthoArizona and Mercy Medical Center in Baltimore, demonstrating active collaboration with healthcare institutions for validation and evaluation. While no other specific technology partnerships were detailed, their focus on a new class of regulated patient-facing AI suggests a need for robust technical infrastructure and potential future collaborations.
RecovryAI emerged from stealth mode after over two years of product development and clinical evaluation, led by a team with extensive experience in clinical, regulatory, and technology fields. The leadership includes co-founders with prior medical device startup exits, numerous medical device patents, and decades of experience in emergency medicine and venture-backed technology companies. Their active pursuit of FDA authorization and ongoing pivotal studies indicate a strong commitment to long-term viability and market entry.

Related Companies

Pear Therapeutics was a pioneer in the field of prescription digital therapeutics (PDTs), developing software-based treatments for various disorders. The company aimed to integrate clinically-validated software applications with traditional treatment paradigms to improve patient outcomes, provide clinicians with smarter engagement and tracking tools, and offer cost-effective solutions for payers. These products were designed to deliver […]

LabSense AI (labsense.ai) is an AI-powered medical lab result interpreter designed to democratize medical literacy globally. The platform aims to help patients understand their lab results in plain language, regardless of their education level or location. It processes lab reports (PDF or photo uploads) and provides explanations for over 86 lab tests, including blood count, […]

Intelligent Medical Objects (IMO) Health is an AI-native clinical data intelligence company that provides a foundation for modern health tech use cases. They leverage a clinician-built ontology and intelligent knowledge graph to create accurate, interoperable, and AI-ready data at scale. IMO Health’s solutions are designed to transform fragmented clinical documentation into structured, contextualized data, which […]

Cloudphysician is a health-tech company that provides AI-powered solutions to transform patient care and safety in intensive care units (ICUs) and emergency departments. The company’s proprietary platform, RADAR, acts as an AI video co-pilot for clinicians, integrating live video, vital signs, and Electronic Medical Records (EMRs) to intelligently interpret events in real-time and guide care […]

Exo Imaging is a pioneering healthcare AI company dedicated to modernizing medical imaging through its high-performance handheld ultrasound platform and artificial intelligence. The company’s mission is to make high-quality, affordable, and easy-to-use medical imaging accessible to healthcare professionals worldwide, enabling them to make critical, real-time decisions that ultimately improve patient outcomes. Exo’s technology combines advances […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.